Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBMP-2 vs PRF in Grade II Furcation Defects
NCT04372420Completed
- Sponsor
- SVS Institute of Dental Sciences
- Start
- Dec 2017
- Primary completion
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of dibotermin alfa in periodontitis (2 arms), sponsored by SVS Institute of Dental Sciences. Primary endpoint: Bone Fill at 6 months. Started Dec 2017; status: completed.
02
Drugs
dibotermin alfa
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT04372420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04372420.